Loading clinical trials...
Loading clinical trials...
A Patient Experience Study With ABBV-444 for Symptom Relief and Tolerability
Conditions
Interventions
ABBV-444
Locations
1
United States
Canyon City Eyecare /ID# 253652
Azusa, California, United States
Start Date
June 27, 2023
Primary Completion Date
October 6, 2023
Completion Date
October 6, 2023
Last Updated
October 15, 2024
NCT07295691
NCT03135327
NCT06771427
NCT06220474
NCT06291194
NCT04685109
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions